Delivery Order SPE2DB22D9353-SPE2DB25FX2EB
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,950.32 by the Defense Logistics Agency (DLA) on June 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes, a pharmaceutical product used in ophthalmology treatment. This delivery order represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on August 14, 2025. The delivery order, which must be completed by September 5, 2025, covers the supply of VABYSMO 6 mg/0.05 ml syringes (0.05 ml units), an injectable pharmaceutical product. This award was issued without a set-aside designation, allowing the vendor to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency on August 26, 2025. The delivery order covers VABYSMO 6 mg/0.05 mL syringes, a prescription pharmaceutical product, with an ultimate completion date of September 17, 2025. This award was not issued under a set-aside designation, allowing the vendor to compete directly in the open...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,983.44 by the Defense Logistics Agency (DLA) on June 2, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes (0.05 mL) with an ultimate completion date of June 24, 2025. This delivery order was issued without a set-aside designation and represents a single-line procurement of this pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.8K on July 21, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order is set to be completed by August 11, 2025, and represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program. The parent contract,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Vabysmo 6 mg/0.05 mL vials. The contract, valued at $2,916.80 with a firm fixed-price structure, is scheduled for completion by October 9, 2025, and carries no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial engagement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,922.15 on September 19, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as a firm fixed-price delivery order with no set-aside designation, calls for the delivery of Vabysmo 6mg/0.05ml, a pharmaceutical product for federal healthcare systems. Performance is scheduled to be completed by...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,966.88 by the Defense Logistics Agency on August 6, 2025, for the supply of Vabysmo 6 mg/0.05 ml syringes. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,224.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a period of performance through April 2, 2024. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB, valued up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Vabysmo 6 mg/0.05 mL syringes valued at $4,475.16. The award, issued on July 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of the...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2EBDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on September 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 ml syringes, a prescription medication used in ophthalmic treatment. The order has an ultimate completion date of September 26, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The SPE2DB indefinite delivery vehicle enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company's contract portfolio demonstrates consistent success in supplying branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems, positioning it as a key distributor for DoD pharmacy and medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/5/25 |